| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.005 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |